mTOR Inhibitor Immunosuppressant [EPC]

55635 reported adverse events

Drugs of this class: SIROLIMUS EVEROLIMUS EVEROLIMUS TABLETS

These side effects are most commonly reported by patients taking drugs of the mTOR Inhibitor Immunosuppressant [EPC] class:

# Side effect Count
0 DEATH 6181
1 DIARRHOEA 4048
2 MALIGNANT NEOPLASM PROGRESSION 3997
3 FATIGUE 3573
4 STOMATITIS 2995
5 NAUSEA 2710
6 DYSPNOEA 2675
7 PYREXIA 2573
8 OFF LABEL USE 2559
9 DRUG INEFFECTIVE 2352
See all common reactions for mTOR Inhibitor Immunosuppressant [EPC]

Drugs of the mTOR Inhibitor Immunosuppressant [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC 79 0.4540
1 TRANSPLANT DYSFUNCTION 487 0.3796
2 PIK3CA-ACTIVATED MUTATION 61 0.3631
3 POLYOMAVIRUS VIRAEMIA 99 0.2742
4 PANCREATIC NEUROENDOCRINE TUMOUR 109 0.2523
5 NEUROENDOCRINE TUMOUR 209 0.2069
6 SMOOTH MUSCLE CELL NEOPLASM 41 0.1971
7 LYMPHOCELE 112 0.1886
8 TRANSPLANT REJECTION 978 0.1722
9 ANGIOMYOLIPOMA 30 0.1676
See all enriched reactions for mTOR Inhibitor Immunosuppressant [EPC]